Early phase development solutions: Accelerating answers for a global pandemic
3 October 2024
Break Through in speed
Learn how Labcorp quickly responded to the global COVID-19 pandemic helping a sponsor reduce their IND program from 12 to 5 months. Labcorp further supported Phase I and II trial work for FDA Emergency Use Authorization.
Latest content early phase development solutions
White Paper
Find out how Labcorp’s programmatic approach can save 30% on your IND program.
Info sheet
Making everyday of your journey count with early phase development solutions.
Early phase development solutions
Experience partnership, continuity and value
Vaccines
Comprehensive suite of discovery in vivo and in vitro services.